Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)

Author: Jihee KO ¹ ; Sun Joon MOON
Author Information

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Publication Type:Letter
From:Diabetes & Metabolism Journal 2023;47(4):571-572
CountryRepublic of Korea
Language:English